Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus placebo as add-on therapy in type 2 diabetes with moderate renal impairment
2011-002968-24Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide add-on with Placebo add-on (2 arms). Primary endpoint: Change in HbA1c from baseline to Week 26. Started Feb 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-002968-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002968-24.